Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer December 2018 16(6):437-444 - Subject
- Language
- ISSN
- 1558-7673